Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on June 6, 2025
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
GlobeNewswire
·
June 6, 2025
USC brain tumor authority to accelerate four clinical trials including lead asset NEO100 nearing Phase 2a completion ahead of schedule Appointment bolsters FDA approval path while company explores AI and quantum computing to enhance drug delivery platform …
Ahead of Apple's WWDC, BrightEdge Data Reveals Mobile AI Web Search Remains Open Frontier
GlobeNewswire
·
June 6, 2025
SAN MATEO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- BrightEdge, the global leader in AI-driven organic search, content, and digital marketing automation, today announced new findings revealing a significant disparity in how users engage with AI-powered …
Blackpoint Cyber and UKON Partner to Redefine Cyber Risk Protection
GlobeNewswire
·
June 6, 2025
DENVER, June 06, 2025 (GLOBE NEWSWIRE) -- Blackpoint Cyber, the world’s fastest and most effective Managed Detection and Response (MDR) provider, today announced a strategic partnership with UKON, a cyber insurance marketplace purpose-built for the modern …
LEX Diagnostics Submits Dual Applications for FDA 510(k) Clearance and CLIA Waiver for Groundbreaking LEX VELO System
GlobeNewswire
·
June 6, 2025
CAMBRIDGESHIRE, United Kingdom, June 06, 2025 (GLOBE NEWSWIRE) -- LEX Diagnostics, a leading innovator in molecular diagnostics, has submitted dual applications to the U.S. Food and Drug Administration (FDA) seeking 510(k) clearance and CLIA waived status …
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
GlobeNewswire
·
June 6, 2025
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced the appointment of …
Cycurion Reports Financial Results for the First Quarter 2025
GlobeNewswire
·
June 6, 2025
MCLEAN, Va., June 06, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, reports financial results for the first quarter ended March 31, 2025, and provides a …
Sagteс Ignites AI Commercialization Surge with US$5 Million in Contracts, Targeting US$50 Million Pipeline in 12 Months
GlobeNewswire
·
June 6, 2025
KUALA LUMPUR, Malaysia, June 06, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), the next-generation provider of customizable AI and automation platforms, today announced the signing of two major commercial …
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
GlobeNewswire
·
June 6, 2025
REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Goldman Sachs …
Sleep Apnea Devices Market worth US$9.3 billion by 2029 | MarketsandMarkets™.
GlobeNewswire
·
June 6, 2025
Delray Beach, FL, June 06, 2025 (GLOBE NEWSWIRE) -- The global sleep apnea devices market valued at US$6.0 billion in 2023, stood at US$6.5 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a …
Turtle Beach Corporation to Participate in Oppenheimer 25th Annual Consumer Growth and E-Commerce Conference
GlobeNewswire
·
June 6, 2025
SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today announced that Cris Keirn, Chief Executive Officer, and Mark Weinswig, Chief Financial Officer, will virtually participate in …
iPower Launches New Joint Venture, United Package NV LLC
GlobeNewswire
·
June 6, 2025
RANCHO CUCAMONGA, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced the formation of United Package NV LLC (“United …
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
GlobeNewswire
·
June 6, 2025
NEEDHAM, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Celldex Therapeutics Announces Election of Denice Torres to its Board of Directors
GlobeNewswire
·
June 6, 2025
HAMPTON, N.J., June 06, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that Denice M. Torres has been elected to the company’s Board of Directors. "We are excited to welcome Denice to the Celldex Board of Directors," said …
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
DALLAS, June 06, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the …
Spur Therapeutics Presents Positive New Preclinical Data on Its Gene Therapy Candidate for GBA1 Parkinson’s Disease at 2025 GBA1 Meeting
GlobeNewswire
·
June 6, 2025
Data show SPR301 lowered α-synuclein, a hallmark of Parkinson’s disease, in cellular models, indicating potential for efficacy at doses with favorable safety Demonstrated greater α-synuclein reductions compared to other gene therapy approaches LONDON, June …
Arcutis to Present New Long-Term Results of ZORYVE® (roflumilast) Cream at the 2025 Revolutionizing Atopic Dermatitis Conference
GlobeNewswire
·
June 6, 2025
New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or minimal itch with ZORYVE cream 0.15% or ZORYVE cream 0. …
American Rebel CEO to Perform at Bristol Dragway and American Rebel Light Beer to be Featured at Trackside Bar and Beer Garden
GlobeNewswire
·
June 6, 2025
PATRIOTISM MEETS HORSEPOWER: ANDY ROSS TO IGNITE BRISTOL DRAGWAY WITH ELECTRIFYING PERFORMANCE! NASHVILLE, TN, June 06, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American Rebel" or the "Company"), creator of American Rebel …
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 6, 2025
SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on June …
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
June 6, 2025
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, …
Functional Safety Market Size expected to reach US$ 13.00 billion by 2031, Experiences Growth Owing to Increased Automation Across Industries | The Insight Partners
GlobeNewswire
·
June 6, 2025
US …